176 related articles for article (PubMed ID: 3705825)
1. [Experience with the use of parlodel in the treatment of Parkinson patients].
Stoliarova LG; Kadykov AS; Shvedkov VV; Pivovarova VM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):219-22. PubMed ID: 3705825
[TBL] [Abstract][Full Text] [Related]
2. [Bromocriptine in Parkinsonian syndromes. Results obtained in a group of patients treated for 8 months].
Quattrini A; Paggi A; Del Pesce M; Di Bella P
Riv Patol Nerv Ment; 1978; 99(3):150-63. PubMed ID: 752907
[TBL] [Abstract][Full Text] [Related]
3. "Long term evaluation of combined treatment of Parkinson disease with L-dopa, peripheral decarboxylase inhibitors and bromocreptine".
Caraceni T; Giovannini P; Girotti F; Parati E; Pederzoli M; Scigliano G
Ital J Neurol Sci; 1981 Dec; 2(4):337-42. PubMed ID: 7333824
[TBL] [Abstract][Full Text] [Related]
4. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
Neĭmark EZ; Evtushenko SK; Dukhovnaia MA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
6. [Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms].
Goulley F; Wolmark Y; Bourdeix I; Chaumet-Riffaud PD
Therapie; 1993; 48(3):233-8. PubMed ID: 7908147
[TBL] [Abstract][Full Text] [Related]
7. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
Evtushenko SK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
9. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome].
Kadykov AS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):174-8. PubMed ID: 944514
[TBL] [Abstract][Full Text] [Related]
10. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
Dufresne JJ
Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
[No Abstract] [Full Text] [Related]
11. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
de Yébenes JG; García-Ruiz PJ; Sánchez-Pernaute R
Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286
[TBL] [Abstract][Full Text] [Related]
12. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Ulm G
Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
[No Abstract] [Full Text] [Related]
13. Clinical administration of parlodel in low doses.
Lipcsey A; Peres A
Adv Neurol; 1984; 40():557-61. PubMed ID: 6695636
[No Abstract] [Full Text] [Related]
14. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
15. [L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
Olsson JE; Duchek M; Ekberg R; Fehling C; Johansson F; Johnels B; Lindvall B; Nordin G; Sidén A; Steg G
Lakartidningen; 1993 Apr; 90(16):1545-8. PubMed ID: 8483351
[No Abstract] [Full Text] [Related]
16. [Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience].
Delwaide PJ; Schoenen J
Rev Med Liege; 1983 May; 38(9):362-6. PubMed ID: 6867529
[No Abstract] [Full Text] [Related]
17. [Use of the preparation L-dopa in parkinsonism].
Proniv DI; Sirotina OS; Bukhovtsev PP; Mis'kiv IaI
Vrach Delo; 1976 Jan; (1):113-6. PubMed ID: 1246837
[No Abstract] [Full Text] [Related]
18. [Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa].
Haas JA; Lakke JP
Ned Tijdschr Geneeskd; 1982 Apr; 126(16):701-5. PubMed ID: 7088202
[No Abstract] [Full Text] [Related]
19. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
Im JH; Ha JH; Cho IS; Lee MC
J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Teychenne PF; Bergsrud D; Elton RL; Racy A
Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
